Archive \ Volume.16 2025 Issue 1

Designing Prescription Verification Systems That Know When the Pharmacist Must Take Over

, ,
  1. Department of Prescription Verification and AI, Faculty of Pharmacy, Polytechnic University of Madrid, Madrid, Spain.
  2. Department of Pharmacy Safety and Human Oversight, Faculty of Pharmacy, University of Barcelona, Barcelona, Spain.

Abstract

Prescription-verification systems increasingly combine rules, clinical knowledge bases, predictive models, and workflow automation. Yet the central safety problem is not simply whether a system can classify a prescription as high or low risk. It is whether the system can recognize when its output is insufficient for continued automation and responsibility must transfer to a pharmacist. Confidence-only automation is inadequate because a high score may coexist with poor calibration, missing clinical context, conflicting evidence, unusual patient–therapy combinations, vulnerability, or high-consequence decisions. This article proposes a non-empirical Prescription-Verification State Model linked to a Pharmacist-Takeover Trigger Framework. The model separates context assembly, automated checking, evidence reconciliation, clarification, pharmacist takeover, adjudication, disposition, and lifecycle monitoring. Takeover is organized around six proposed trigger classes: uncertainty, conflicting evidence, missing context, unusual combinations, vulnerable patients, and high-consequence decisions. A related takeover contract specifies the reason for escalation, unresolved information, urgency, completed checks, required professional action, fallback behavior, and documentation. Evaluation must extend beyond model discrimination to calibration, trigger sensitivity, missed takeover, unnecessary takeover, timing, workload displacement, interface comprehension, subgroup performance, and post-deployment change. Governance must define authority for activation, modification, suspension, requalification, and retirement. The framework is an original conceptual synthesis rather than a validated clinical system, guideline, or regulatory standard. Its trigger logic, state transitions, thresholds, and responsibility boundaries require empirical testing in specific pharmacy settings before decision use.


Downloads: 22
Views: 111

How to cite:
Vancouver
Martínez S, Gómez C, Navarro L. Designing Prescription Verification Systems That Know When the Pharmacist Must Take Over. Arch Pharm Pract. 2025;16(1):69-77. https://doi.org/10.51847/acWJvHeaeM
APA
Martínez, S., Gómez, C., & Navarro, L. (2025). Designing Prescription Verification Systems That Know When the Pharmacist Must Take Over. Archives of Pharmacy Practice, 16(1), 69-77. https://doi.org/10.51847/acWJvHeaeM

Download Citation
References
  1. Panagioti M, Khan K, Keers RN, Abuzour A, Phipps D, Kontopantelis E, et al. Prevalence, severity, and nature of preventable patient harm across medical care settings: Systematic review and meta-analysis. BMJ. 2019;366. doi:10.1136/bmj.l4185
  2. Chalasani SH, Syed J, Ramesh M, Patil V, Pramod Kumar TM. Artificial intelligence in the field of pharmacy practice: A literature review. Explor Res Clin Soc Pharm. 2023;12:100346. doi:10.1016/j.rcsop.2023.100346
  3. Graafsma J, Murphy RM, van de Garde EMW, Karapinar-Çarkit F, Derijks HJ, Hoge RHL, et al. The use of artificial intelligence to optimize medication alerts generated by clinical decision support systems: A scoping review. J Am Med Inform Assoc. 2024;31(6):1411-22. doi:10.1093/jamia/ocae076
  4. Corny J, Rajkumar A, Martin O, Dode X, Lajonchère JP, Billuart O, et al. A machine learning-based clinical decision support system to identify prescriptions with a high risk of medication error. J Am Med Inform Assoc. 2020;27(11):1688-94. doi:10.1093/jamia/ocaa154
  5. Feather C, Appelbaum N, Darzi A, Dean Franklin B. Indication documentation and indication-based prescribing within electronic prescribing systems: A systematic review and narrative synthesis. BMJ Qual Saf. 2023;32(6):357-68. doi:10.1136/bmjqs-2022-015452
  6. Begoli E, Bhattacharya T, Kusnezov D. The need for uncertainty quantification in machine-assisted medical decision making. Nat Mach Intell. 2019;1(1):20-3. doi:10.1038/s42256-018-0004-1
  7. Kompa B, Snoek J, Beam AL. Second opinion needed: Communicating uncertainty in medical machine learning. NPJ Digit Med. 2021;4(1):4. doi:10.1038/s41746-020-00367-3
  8. Van Calster B, McLernon DJ, van Smeden M, Wynants L, Steyerberg EW; Topic Group ‘Evaluating Diagnostic Tests and Prediction Models’ of the STRATOS Initiative. Calibration: The Achilles heel of predictive analytics. BMC Med. 2019;17(1):230. doi:10.1186/s12916-019-1466-7
  9. Ghassemi M, Oakden-Rayner L, Beam AL. The false hope of current approaches to explainable artificial intelligence in health care. Lancet Digit Health. 2021;3(11). doi:10.1016/S2589-7500(21)00208-9
  10. Lyell D, Coiera E. Automation bias and verification complexity: A systematic review. J Am Med Inform Assoc. 2017;24(2):423-31. doi:10.1093/jamia/ocw105
  11. Wong A, Amato MG, Seger DL, Rehr C, Wright A, Slight SP, et al. Prospective evaluation of medication-related clinical decision support over-rides in the intensive care unit. BMJ Qual Saf. 2018;27(9):718-24. doi:10.1136/bmjqs-2017-007531
  12. Abdo A, Gallay L, Vallecillo T, Clarenne J, Quillet P, Vuiblet V, et al. A machine learning-based clinical predictive tool to identify patients at high risk of medication errors. Sci Rep. 2024;14(1):32022. doi:10.1038/s41598-024-83631-w
  13. Nanji KC, Garabedian PM, Langlieb ME, Rui A, Tabayoyong LL, Sampson M, et al. Usability of a perioperative medication-related clinical decision support software application: A randomized controlled trial. J Am Med Inform Assoc. 2022;29(8):1416-24. doi:10.1093/jamia/ocac035
  14. Sutton RT, Pincock D, Baumgart DC, Sadowski DC, Fedorak RN, Kroeker KI. An overview of clinical decision support systems: Benefits, risks, and strategies for success. NPJ Digit Med. 2020;3:17. doi:10.1038/s41746-020-0221-y
  15. Légat L, Van Laere S, Nyssen M, Steurbaut S, Dupont AG, Cornu P. Clinical decision support systems for drug allergy checking: Systematic review. J Med Internet Res. 2018;20(9). doi:10.2196/jmir.8206
  16. Muylle KM, Gentens K, Dupont AG, Cornu P. Evaluation of an optimized context-aware clinical decision support system for drug-drug interaction screening. Int J Med Inform. 2021;148:104393. doi:10.1016/j.ijmedinf.2021.104393
  17. Van De Sijpe G, Walgraeve K, Van Laer E, Quintens C, Machiels C, Foulon V, et al. The impact of customized screening intervals on the burden of drug-drug interaction alerts: An interrupted time series analysis. J Med Syst. 2024;48(1):93. doi:10.1007/s10916-024-02113-8
  18. Parekh N, Ali K, Davies JG, Stevenson JM, Banya W, Nyangoma S, et al. Medication-related harm in older adults following hospital discharge: Development and validation of a prediction tool. BMJ Qual Saf. 2020;29(2):142-53. doi:10.1136/bmjqs-2019-009587
  19. Page N, Baysari MT, Westbrook JI. A systematic review of the effectiveness of interruptive medication prescribing alerts in hospital computerized order entry systems to change prescriber behavior and improve patient safety. Int J Med Inform. 2017;105:22-30. doi:10.1016/j.ijmedinf.2017.05.011
  20. Hussain MI, Reynolds TL, Zheng K. Medication safety alert fatigue may be reduced via interaction design and clinical role tailoring: A systematic review. J Am Med Inform Assoc. 2019;26(10):1141-9. doi:10.1093/jamia/ocz095
  21. Ancker JS, Edwards A, Nosal S, Hauser D, Mauer E, Kaushal R; HITEC Investigators. Effects of workload, work complexity, and repeated alerts on alert fatigue in a clinical decision support system. BMC Med Inform Decis Mak. 2017;17(1):36. doi:10.1186/s12911-017-0430-8
  22. McCoy AB, Russo EM, Johnson KB, Addison B, Patel N, Wanderer JP, et al. Clinician collaboration to improve clinical decision support: The Clickbusters initiative. J Am Med Inform Assoc. 2022;29(6):1050-9. doi:10.1093/jamia/ocac027
  23. Vasey B, Nagendran M, Campbell B, Clifton DA, Collins GS, Denaxas S, et al.; DECIDE-AI Expert Group. Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI. Nat Med. 2022;28(5):924-33. doi:10.1038/s41591-022-01772-9
  24. Liu X, Cruz Rivera S, Moher D, Calvert MJ, Denniston AK; SPIRIT-AI and CONSORT-AI Working Group. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: The CONSORT-AI extension. Nat Med. 2020;26(9):1364-74. doi:10.1038/s41591-020-1034-x
  25. Cruz Rivera S, Liu X, Chan AW, Denniston AK, Calvert MJ; SPIRIT-AI and CONSORT-AI Working Group. Guidelines for clinical trial protocols for interventions involving artificial intelligence: The SPIRIT-AI extension. Nat Med. 2020;26(9):1351-63. doi:10.1038/s41591-020-1037-7
  26. Collins GS, Dhiman P, Andaur Navarro CL, Ma J, Hooft L, Reitsma JB, et al. TRIPOD+AI statement: Updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024;385. doi:10.1136/bmj-2023-078378
  27. Kelly CJ, Karthikesalingam A, Suleyman M, Corrado G, King D. Key challenges for delivering clinical impact with artificial intelligence. BMC Med. 2019;17(1):195. doi:10.1186/s12916-019-1426-2
  28. Wiens J, Saria S, Sendak M, Ghassemi M, Liu VX, Doshi-Velez F, et al. Do no harm: A roadmap for responsible machine learning for health care. Nat Med. 2019;25(9):1337-40. doi:10.1038/s41591-019-0548-6
  29. Henry KE, Adams R, Parent C, Soleimani H, Sridharan A, Johnson L, et al. Factors driving provider adoption of the TREWS machine learning-based early warning system and its effects on sepsis treatment timing. Nat Med. 2022;28(7):1447-54. doi:10.1038/s41591-022-01895-z
  30. Damschroder LJ, Reardon CM, Widerquist MAO, Lowery J. The updated Consolidated Framework for Implementation Research based on user feedback. Implement Sci. 2022;17(1):75. doi:10.1186/s13012-022-01245-0
  31. Obermeyer Z, Powers B, Vogeli C, Mullainathan S. Dissecting racial bias in an algorithm used to manage the health of populations. Science. 2019;366(6464):447-53. doi:10.1126/science.aax2342
  32. McCradden MD, Joshi S, Mazwi M, Anderson JA. Ethical limitations of algorithmic fairness solutions in health care machine learning. Lancet Digit Health. 2020;2(5). doi:10.1016/S2589-7500(20)30065-0
  33. Cabitza F, Rasoini R, Gensini GF. Unintended consequences of machine learning in medicine. JAMA. 2017;318(6):517-8. doi:10.1001/jama.2017.7797
  34. Subbaswamy A, Saria S. From development to deployment: Dataset shift, causality, and shift-stable models in health AI. Biostatistics. 2020;21(2):345-52. doi:10.1093/biostatistics/kxz041

 

 


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.